BRANDYWINE REALTY TRUST (BDN)

US1053682035 - REIT

5.465  -0.04 (-0.82%)

Fundamental Rating

3

BDN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of BDN have multiple concerns. BDN does not seem to be growing, but still is valued expensively.



3

1. Profitability

1.1 Basic Checks

In the past year BDN has reported negative net income.
BDN had a positive operating cash flow in the past year.
BDN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years BDN had a positive operating cash flow.

1.2 Ratios

BDN has a Return On Assets of -8.60%. This is amonst the worse of the industry: BDN underperforms 95.28% of its industry peers.
Looking at the Return On Equity, with a value of -28.19%, BDN is doing worse than 92.13% of the companies in the same industry.
With a Return On Invested Capital value of 2.45%, BDN perfoms like the industry average, outperforming 42.52% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BDN is in line with the industry average of 3.10%.
The last Return On Invested Capital (2.45%) for BDN is above the 3 year average (2.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -8.6%
ROE -28.19%
ROIC 2.45%
ROA(3y)-1.2%
ROA(5y)1.01%
ROE(3y)-3.66%
ROE(5y)1.61%
ROIC(3y)2.11%
ROIC(5y)2.19%

1.3 Margins

The Operating Margin of BDN (20.58%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BDN has declined.
BDN has a worse Gross Margin (63.66%) than 65.35% of its industry peers.
In the last couple of years the Gross Margin of BDN has remained more or less at the same level.
Industry RankSector Rank
OM 20.58%
PM (TTM) N/A
GM 63.66%
OM growth 3Y-1.77%
OM growth 5Y-2.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.82%
GM growth 5Y1.17%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BDN is destroying value.
The number of shares outstanding for BDN has been increased compared to 1 year ago.
BDN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BDN has a worse debt to assets ratio.

2.2 Solvency

BDN has an Altman-Z score of -0.32. This is a bad value and indicates that BDN is not financially healthy and even has some risk of bankruptcy.
BDN has a Altman-Z score of -0.32. This is amonst the worse of the industry: BDN underperforms 87.40% of its industry peers.
BDN has a debt to FCF ratio of 57.51. This is a negative value and a sign of low solvency as BDN would need 57.51 years to pay back of all of its debts.
The Debt to FCF ratio of BDN (57.51) is comparable to the rest of the industry.
BDN has a Debt/Equity ratio of 2.06. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.06, BDN is not doing good in the industry: 77.17% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF 57.51
Altman-Z -0.32
ROIC/WACC0.4
WACC6.09%

2.3 Liquidity

BDN has a Current Ratio of 1.25. This is a normal value and indicates that BDN is financially healthy and should not expect problems in meeting its short term obligations.
BDN has a Current ratio (1.25) which is in line with its industry peers.
A Quick Ratio of 1.25 indicates that BDN should not have too much problems paying its short term obligations.
BDN has a Quick ratio of 1.25. This is comparable to the rest of the industry: BDN outperforms 56.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1.25

3

3. Growth

3.1 Past

The earnings per share for BDN have decreased strongly by -2471.43% in the last year.
Looking at the last year, BDN shows a small growth in Revenue. The Revenue has grown by 0.05% in the last year.
BDN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.11% yearly.
EPS 1Y (TTM)-2471.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-638.46%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-1.28%
Revenue growth 5Y-1.11%
Sales Q2Q%1.86%

3.2 Future

BDN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.78% yearly.
BDN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.65% yearly.
EPS Next Y15.69%
EPS Next 2Y28.06%
EPS Next 3Y22.78%
EPS Next 5YN/A
Revenue Next Year-0.18%
Revenue Next 2Y1.05%
Revenue Next 3Y2.68%
Revenue Next 5Y1.65%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

BDN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BDN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

BDN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BDN is cheaper than 78.74% of the companies in the same industry.
70.08% of the companies in the same industry are more expensive than BDN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.99
EV/EBITDA 11.09

4.3 Compensation for Growth

BDN's earnings are expected to grow with 22.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.06%
EPS Next 3Y22.78%

5

5. Dividend

5.1 Amount

BDN has a Yearly Dividend Yield of 10.70%, which is a nice return.
BDN's Dividend Yield is rather good when compared to the industry average which is at 15.86. BDN pays more dividend than 90.55% of the companies in the same industry.
BDN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 10.7%

5.2 History

The dividend of BDN decreases each year by -0.08%.
BDN has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-0.08%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

BDN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-33.66%
EPS Next 2Y28.06%
EPS Next 3Y22.78%

BRANDYWINE REALTY TRUST

NYSE:BDN (12/30/2024, 12:00:29 PM)

5.465

-0.04 (-0.82%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-22 2024-10-22/amc
Earnings (Next)02-04 2025-02-04/amc
Inst Owners88.96%
Inst Owner Change-0.1%
Ins Owners2.48%
Ins Owner Change-0.19%
Market Cap943.64M
Analysts68
Price Target5.51 (0.82%)
Short Float %5.88%
Short Ratio4.79
Dividend
Industry RankSector Rank
Dividend Yield 10.7%
Dividend Growth(5Y)-0.08%
DP-33.66%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-08 2025-01-08 (0.15)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-871.6%
Min EPS beat(2)-2000.99%
Max EPS beat(2)257.79%
EPS beat(4)1
Avg EPS beat(4)-745.1%
Min EPS beat(4)-2000.99%
Max EPS beat(4)257.79%
EPS beat(8)3
Avg EPS beat(8)-193.89%
EPS beat(12)7
Avg EPS beat(12)109.85%
EPS beat(16)9
Avg EPS beat(16)105.29%
Revenue beat(2)0
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-2.06%
Max Revenue beat(2)-1.68%
Revenue beat(4)0
Avg Revenue beat(4)-2.25%
Min Revenue beat(4)-3.91%
Max Revenue beat(4)-1.35%
Revenue beat(8)1
Avg Revenue beat(8)-1.47%
Revenue beat(12)3
Avg Revenue beat(12)-0.43%
Revenue beat(16)3
Avg Revenue beat(16)-0.81%
PT rev (1m)0%
PT rev (3m)5.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)25%
EPS NY rev (1m)0%
EPS NY rev (3m)-113.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.84
P/FCF 23.99
P/OCF 4.96
P/B 0.86
P/tB 0.86
EV/EBITDA 11.09
EPS(TTM)-1.8
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)0.23
FCFY4.17%
OCF(TTM)1.1
OCFY20.14%
SpS2.98
BVpS6.36
TBVpS6.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.6%
ROE -28.19%
ROCE 3.1%
ROIC 2.45%
ROICexc 2.47%
ROICexgc 2.57%
OM 20.58%
PM (TTM) N/A
GM 63.66%
FCFM 7.65%
ROA(3y)-1.2%
ROA(5y)1.01%
ROE(3y)-3.66%
ROE(5y)1.61%
ROIC(3y)2.11%
ROIC(5y)2.19%
ROICexc(3y)2.13%
ROICexc(5y)2.22%
ROICexgc(3y)2.2%
ROICexgc(5y)2.32%
ROCE(3y)2.67%
ROCE(5y)2.77%
ROICexcg growth 3Y-2.61%
ROICexcg growth 5Y-2.5%
ROICexc growth 3Y-1.43%
ROICexc growth 5Y-1.69%
OM growth 3Y-1.77%
OM growth 5Y-2.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.82%
GM growth 5Y1.17%
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF 57.51
Debt/EBITDA 7.9
Cap/Depr 83.41%
Cap/Sales 29.34%
Interest Coverage 0.87
Cash Conversion 66.36%
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 1.25
Altman-Z -0.32
F-Score4
WACC6.09%
ROIC/WACC0.4
Cap/Depr(3y)104.18%
Cap/Depr(5y)102.87%
Cap/Sales(3y)37.44%
Cap/Sales(5y)36.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2471.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-638.46%
EPS Next Y15.69%
EPS Next 2Y28.06%
EPS Next 3Y22.78%
EPS Next 5YN/A
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-1.28%
Revenue growth 5Y-1.11%
Sales Q2Q%1.86%
Revenue Next Year-0.18%
Revenue Next 2Y1.05%
Revenue Next 3Y2.68%
Revenue Next 5Y1.65%
EBIT growth 1Y7.66%
EBIT growth 3Y-3.03%
EBIT growth 5Y-3.76%
EBIT Next Year230.86%
EBIT Next 3Y50.49%
EBIT Next 5YN/A
FCF growth 1Y144.09%
FCF growth 3Y-17.89%
FCF growth 5YN/A
OCF growth 1Y-4.2%
OCF growth 3Y-7.75%
OCF growth 5Y-4.85%